Trending Now
Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) Secures FDA Green Light For Upneeq
Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) recently announced that Upneeq, its innovative treatment for ptosis or acquired blepharoptosis, received regulatory approval from the FDA.
Acquired blepharoptosis is...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Adaptimmune Therapeutics (NASDAQ:ADAP) Presents Promising ADP-A2AFP Phase 1 Study Results In...
Adaptimmune Therapeutics plc (NASDAQ:ADAP) recently released data from the Phase 1 ADP-A2AFP SPEAR T-cells study targeting AFP during the International Liver Congress.
The favorable safety...
MAKE IT MODERN
LATEST REVIEWS
Selecta Biosciences Inc. (NASDAQ:SELB) And AskBio Granted Orphan Drug Designation For...
Selecta Biosciences Inc. (NASDAQ:SELB) and Asklepios Biopharmaceuticals Inc. (AskBio) have announced receipt of Orphan Drug designation for MMA-101 from the US FDA....
MAKE IT MODERN
PERFORMANCE TRAINING
CleanGo Innovations Inc (SOFSF) receives the most significant single purchase order in the Company’s...
According to researchandmarkets.com, amid the COVID-19 crisis, the global market for Household Cleaners, estimated at US$35.4 Billion in the year 2020, is...
Kintara Therapeutics Inc. (NASDAQ: KTRA) Releases Topline Data from Open-Label GBM Clinical Study
Kintara Therapeutics Inc. (NASDAQ: KTRA) has announced topline data from its newly-diagnosed adjuvant arm of the open-label second phase clinical trial being carried at the...
Affimed N.V. (AFMD) Soars Over 68% on Promising AFM24 Data and Strong Market Performance
Affimed N.V. (NASDAQ: AFMD) has captured significant attention in the biotech market with its recent stock performance. The company’s shares soared 68.51%...
Clinical Trial of Experimental Ulcerative Colitis Drug Humming Along
Investors generally expect clinical trials to take a long time. That’s not always the case. Take Innovation Pharmaceuticals (OTCQB:IPIX), for example. Looking...
Axsome Therapeutics Inc. (NASDAQ:AXSM) Announces Development Status For AXS-05 In The Treatment Of Alzheimer’s...
There are hundreds of people facing unsatisfactory treatments for CNS disorders. Due to the limitation of treatment options, Axsome Therapeutics Inc (NASDAQ:AXSM) has taken...
MAKE IT MODERN
